Rodney R. Miles
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research
Most-Cited Works
- → The genetic landscape of mutations in Burkitt lymphoma(2012)596 cited
- → Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children(2020)304 cited
- → NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers(2013)296 cited
- → The whole-genome landscape of Burkitt lymphoma subtypes(2019)195 cited
- → Zebrafish screen identifies novel compound with selective toxicity against leukemia(2012)156 cited
- → The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling(2010)147 cited
- → Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma(2022)138 cited
- → Comparison of Serum and Heparinized Plasma Samples for Measurement of Chemistry Analytes(2004)112 cited
- → Pediatric diffuse large B‐cell lymphoma demonstrates a high proliferation index, frequent c‐Myc protein expression, and a high incidence of germinal center subtype: Report of the French–American–British (FAB) international study group(2008)97 cited
- → Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting(2020)83 cited